Sophie Gad
Paris, 75014, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: October 23, 2025
Microcristaux de cholestérol dans le liquide synovial et polyarthrite rhumatoïde
Journal: Annales de biologie clinique
Published: April 19, 2024
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.
Journal: Seminars in cancer biology
Published: July 31, 2023
DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 05, 2023
Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway.
Journal: Oncology letters
Published: May 25, 2021
Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumors.
Journal: Cancer genetics
Published: December 08, 2020
Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Journal: International journal of oncology
Published: November 15, 2017
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2.
Journal: Anticancer research
Published: December 06, 2015
Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
Journal: Oncotarget
Published: October 07, 2015
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
Journal: European urology
Published: August 21, 2015
Last Updated: 09/26/2026